Tearsheet

Axcelis Technologies (ACLS)


Market Price (2/3/2026): $83.2 | Market Cap: $2.6 Bil
Sector: Information Technology | Industry: Semiconductor Materials & Equipment

Axcelis Technologies (ACLS)


Market Price (2/3/2026): $83.2
Market Cap: $2.6 Bil
Sector: Information Technology
Industry: Semiconductor Materials & Equipment

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.1%
Weak multi-year price returns
2Y Excs Rtn is -77%, 3Y Excs Rtn is -94%
Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -21%, Rev Chg QQuarterly Revenue Change % is -17%
1 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -15%
Meaningful short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 15%
Key risks
ACLS key risks include [1] over-reliance on a potentially peaking SiC/EV ion implant supercycle, Show more.
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 16%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 15%
  
3 Megatrend and thematic drivers
Megatrends include Artificial Intelligence, Electric Vehicles & Autonomous Driving, and 5G & Advanced Connectivity. Themes include AI Chips, Show more.
  
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.1%
1 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -15%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 16%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 15%
3 Megatrend and thematic drivers
Megatrends include Artificial Intelligence, Electric Vehicles & Autonomous Driving, and 5G & Advanced Connectivity. Themes include AI Chips, Show more.
4 Weak multi-year price returns
2Y Excs Rtn is -77%, 3Y Excs Rtn is -94%
5 Meaningful short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 15%
6 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -21%, Rev Chg QQuarterly Revenue Change % is -17%
7 Key risks
ACLS key risks include [1] over-reliance on a potentially peaking SiC/EV ion implant supercycle, Show more.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Axcelis Technologies (ACLS) stock has gained about 5% since 10/31/2025 because of the following key factors:

1. Axcelis Technologies (ACLS) reported stronger-than-expected third-quarter 2025 financial results. On November 4, 2025, the company announced earnings per share of $1.21, surpassing analyst estimates of $1.01, and revenue of $213.61 million, exceeding the $200.06 million consensus. Although the stock initially saw a slight dip after the announcement, it subsequently rebounded, rising by 9.5% from its post-earnings low.

2. The stock benefited from positive analyst sentiment and increased price targets. During the period, several Wall Street analysts either maintained favorable ratings or upgraded their price targets for Axcelis Technologies. For instance, on October 2, 2025, Benchmark upgraded the stock to a "Buy" with a $105 price target, while DA Davidson maintained a "Strong Buy" with a $110 target. More recently, on January 21, 2026, B. Riley Securities raised its price objective for ACLS from $84.00 to $94.00. The consensus analyst rating for ACLS is "Buy," with a median price target of $97.50, suggesting a potential upside.

Show more

Stock Movement Drivers

Fundamental Drivers

The 4.6% change in ACLS stock from 10/31/2025 to 2/3/2026 was primarily driven by a 19.8% change in the company's P/E Multiple.
(LTM values as of)103120252032026Change
Stock Price ($)79.5683.204.6%
Change Contribution By: 
Total Revenues ($ Mil)896853-4.8%
Net Income Margin (%)17.7%15.9%-9.9%
P/E Multiple16.019.219.8%
Shares Outstanding (Mil)32311.8%
Cumulative Contribution4.6%

LTM = Last Twelve Months as of date shown

Market Drivers

10/31/2025 to 2/3/2026
ReturnCorrelation
ACLS6.0% 
Market (SPY)1.1%68.1%
Sector (XLK)-5.5%64.4%

Fundamental Drivers

The 22.9% change in ACLS stock from 7/31/2025 to 2/3/2026 was primarily driven by a 56.1% change in the company's P/E Multiple.
(LTM values as of)73120252032026Change
Stock Price ($)67.6983.2022.9%
Change Contribution By: 
Total Revenues ($ Mil)958853-11.0%
Net Income Margin (%)18.6%15.9%-14.3%
P/E Multiple12.319.256.1%
Shares Outstanding (Mil)32313.1%
Cumulative Contribution22.9%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2025 to 2/3/2026
ReturnCorrelation
ACLS24.6% 
Market (SPY)9.4%53.1%
Sector (XLK)8.3%54.2%

Fundamental Drivers

The 22.4% change in ACLS stock from 1/31/2025 to 2/3/2026 was primarily driven by a 92.2% change in the company's P/E Multiple.
(LTM values as of)13120252032026Change
Stock Price ($)68.0083.2022.4%
Change Contribution By: 
Total Revenues ($ Mil)1,076853-20.7%
Net Income Margin (%)20.6%15.9%-22.8%
P/E Multiple10.019.292.2%
Shares Outstanding (Mil)33314.0%
Cumulative Contribution22.4%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2025 to 2/3/2026
ReturnCorrelation
ACLS24.1% 
Market (SPY)15.6%60.1%
Sector (XLK)23.7%63.4%

Fundamental Drivers

The -24.3% change in ACLS stock from 1/31/2023 to 2/3/2026 was primarily driven by a -15.4% change in the company's Net Income Margin (%).
(LTM values as of)13120232032026Change
Stock Price ($)109.9583.20-24.3%
Change Contribution By: 
Total Revenues ($ Mil)860853-0.8%
Net Income Margin (%)18.8%15.9%-15.4%
P/E Multiple22.419.2-14.6%
Shares Outstanding (Mil)33315.5%
Cumulative Contribution-24.3%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2023 to 2/3/2026
ReturnCorrelation
ACLS-23.3% 
Market (SPY)75.9%59.6%
Sector (XLK)113.3%65.2%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
ACLS Return156%6%63%-46%15%11%205%
Peers Return76%-31%81%-0%59%24%331%
S&P 500 Return27%-19%24%23%16%2%86%

Monthly Win Rates [3]
ACLS Win Rate67%42%58%25%42%100% 
Peers Win Rate72%35%68%47%60%90% 
S&P 500 Win Rate75%42%67%75%67%100% 

Max Drawdowns [4]
ACLS Max Drawdown-2%-36%-1%-47%-39%0% 
Peers Max Drawdown0%-46%-2%-10%-26%0% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-1% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: AMAT, LRCX, KLAC, VECO, ONTO. See ACLS Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/3/2026 (YTD)

How Low Can It Go

Unique KeyEventACLSS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-41.9%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven72.1%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven164 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-53.3%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven114.3%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven109 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-61.6%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven160.5%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven568 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-97.9%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven4723.5%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven5,117 days1,480 days

Compare to AMAT, LRCX, KLAC, VECO, ONTO

In The Past

Axcelis Technologies's stock fell -41.9% during the 2022 Inflation Shock from a high on 3/24/2022. A -41.9% loss requires a 72.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Axcelis Technologies (ACLS)

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.

AI Analysis | Feedback

Here are 1-2 brief analogies for Axcelis Technologies (ACLS):

  • ACLS is like ASML, but focused specifically on ion implantation equipment for chip manufacturing.
  • ACLS is like a specialized version of Applied Materials, concentrating solely on ion implanters for the semiconductor industry.

AI Analysis | Feedback

  • Purion Ion Implantation Systems: These systems are critical tools used in semiconductor manufacturing to precisely introduce dopant ions into silicon wafers, forming the transistors and other structures of integrated circuits.
  • Aftermarket Parts and Services: This category includes spare parts, equipment upgrades, maintenance services, and customer support necessary to ensure the optimal performance and longevity of their installed ion implantation base.

AI Analysis | Feedback

Axcelis Technologies (ACLS) primarily sells its products and services to other companies, specifically semiconductor manufacturers (B2B), providing ion implantation equipment and related services.

Major Customers of Axcelis Technologies (ACLS):

Based on recent financial disclosures (e.g., 10-K filings), Axcelis Technologies has significant revenue concentration with a few key customers:

  • Samsung Electronics Co., Ltd. (Symbol: 005930.KS - Primarily traded on the Korea Exchange)
  • Taiwan Semiconductor Manufacturing Company Limited (TSMC) (Symbol: TSM - Traded on NYSE)
  • Micron Technology, Inc. (Symbol: MU - Traded on NASDAQ)
  • SK Hynix Inc. (Symbol: 000660.KS - Primarily traded on the Korea Exchange)

AI Analysis | Feedback

null

AI Analysis | Feedback

Russell Low, President and Chief Executive Officer

Dr. Russell Low assumed the role of President and Chief Executive Officer of Axcelis Technologies in May 2023. He joined Axcelis in October 2016, initially serving as Executive Vice President, Engineering, and later as Executive Vice President, Global Customer and Engineering Operations starting in January 2021. Before his tenure at Axcelis, Dr. Low held leadership positions at Veeco Instruments, where he was Vice President of Engineering for the MOCVD Business Unit since 2013 and Senior Director of Engineering for the Molecular Beam Epitaxy Business Unit from 2012. His career also includes various roles at Varian Semiconductor Equipment Associates from 2003 to 2012, most recently as Director of Technology, and engineering positions at Applied Materials, Inc. Dr. Low earned his Ph.D. in Physical Chemistry from Oxford University and an Executive MBA from the Massachusetts Institute of Technology.

James Coogan, Executive Vice President and Chief Financial Officer

James Coogan joined Axcelis as Executive Vice President and Chief Financial Officer in September 2023. He brings over 20 years of experience in finance, accounting, and investor relations, with a recent focus on the aerospace and defense sector. Prior to Axcelis, Mr. Coogan served as Senior Vice President, Chief Financial Officer at Kaman Corporation. During his 15 years at Kaman, he held several management positions, including Vice President, Investor Relations and Corporate Development, and Assistant Vice President, External Reporting and SEC Compliance. He holds a Master of Business Administration from Yale School of Management, a Master of Science in Accounting, and a Bachelor of Science in Business Administration, Accounting from the University of Connecticut.

Mary G. Puma, Executive Chairperson

Mary G. Puma serves as the Executive Chairperson of Axcelis Technologies. She had a distinguished 25-year career at Axcelis, including 22 years as CEO, before transitioning from CEO in May 2023. Ms. Puma joined Axcelis through Eaton Corporation and, after assisting with the company's initial public offering in 2000, became President and Chief Operating Officer. Before joining Eaton, she spent 15 years in various marketing and general management roles at General Electric Company.

Lynnette C. Fallon, Executive Vice President, Human Resources & Legal & General Counsel

Lynnette C. Fallon has been an Executive Vice President of HR & Legal at Axcelis Technologies Inc. since May 2005. She also serves as the General Counsel.

Greg Redinbo, Executive Vice President, Marketing and Applications

Greg Redinbo holds the position of Executive Vice President, Marketing and Applications at Axcelis Technologies.

AI Analysis | Feedback

Key Risks to Axcelis Technologies (ACLS)

  1. Cyclicality of the Semiconductor Industry and Dependence on Specific Market Segments: Axcelis Technologies is highly susceptible to the cyclical nature of the semiconductor industry. Its recent elevated profitability has been significantly driven by what has been described as an "ion implant Supercycle," particularly related to Silicon Carbide (SiC) chips used in Electric Vehicles (EVs). However, there are indications that this supercycle may have peaked, with cooled EV demand expectations and industry data suggesting a downturn. This cyclicality leads to significant fluctuations in financial results, with forecasted declines in earnings and revenue over the next few years. The company's revenue is derived from the sale of a small number of expensive products, meaning each sale or failure to make a sale can significantly impact quarterly results. The memory segment of the business has also experienced instability.
  2. High Customer Concentration in China and Geopolitical Risks: A substantial portion of Axcelis's revenue is generated from customers in China, accounting for over 55% of total revenue and 65% of shipped system sales. This concentration exposes the company to considerable risks, including sudden shifts in demand, potential export restrictions, and geopolitical headwinds. Moreover, there is an increasing push for self-sufficiency in semiconductors by Chinese companies, which could lead to local chipmakers being mandated to source equipment from domestic suppliers, even if less technologically advanced, thereby impacting Axcelis's market share in this crucial region.
  3. Intensifying Competition and Potential Technology Erosion: Axcelis faces the risk of its market leadership eroding due to intensifying competition. Competitors, such as Varian, have been closing the technological gap in high-energy ion implanters. Additionally, Chinese companies are emerging as competitive threats, further challenging Axcelis's position. This increased competition can lead to pressure on sales and pricing, potentially impacting the company's profitability and market share.

AI Analysis | Feedback

null

AI Analysis | Feedback

Axcelis Technologies (ACLS) primarily operates in the semiconductor manufacturing equipment industry, with its main products and services centered around ion implantation and, to a lesser extent, dry strip processes.

Addressable Markets for Axcelis Technologies' Main Products:

  • Ion Implantation Equipment:
    • The global ion implanter market was valued at approximately USD 945.00 million in 2021 and is projected to reach about USD 1,396.20 million by 2029, demonstrating a compound annual growth rate (CAGR) of 5.00% during the forecast period of 2022-2029.
    • Another estimate indicates the global ion implanter market size reached USD 1.64 billion in 2024 and is expected to grow to USD 2.38 billion by 2033, with a CAGR of 4.21% during 2025-2033.
    • For the specific niche of ion implantation equipment for Silicon Carbide (SiC) semiconductor manufacturing, the global demand is estimated to exceed USD 6 billion in capital expenditure by 2030.
    • North America holds a dominant share in the ion implanter market, while the Asia-Pacific region is anticipated to exhibit lucrative growth.
  • Dry Strip Equipment:
    • The global semiconductor dry strip equipment market is projected to grow from USD 283.370 million in 2025 to USD 351.671 million by 2030, at a CAGR of 4.41%.

AI Analysis | Feedback

Expected Drivers of Future Revenue Growth for Axcelis Technologies (ACLS)

  • Growth in Silicon Carbide (SiC) Applications: Axcelis Technologies is strongly positioned to benefit from the expanding silicon carbide market, driven by increasing demand from electric vehicles (EVs), AI applications, and the broader electrification trend. The company's Purion Power Series in SiC implantation is specifically noted to have significant growth potential, with the SiC market projected for substantial expansion over the next few years.
  • Expansion of Customer Support and Integration (CS&I) Services: The CS&I segment, which includes aftermarket parts, services, and upgrades, has consistently demonstrated strong performance and is a key driver of recurring revenue. This growth is attributed to a successful aftermarket strategy and the continuous expansion of Axcelis' installed base of tools, providing stable and high-margin business.
  • Recovery and Demand in the Memory Market: While 2025 is anticipated to be a period of digestion in some markets, Axcelis expects a cyclical recovery in the memory market, particularly for DRAM and High Bandwidth Memory (HBM) driven by AI applications, starting in 2026. This recovery is poised to be a significant growth catalyst.
  • Advanced Logic Market Expansion and New Product Innovation: Axcelis is actively expanding its footprint in the Advanced Logic market and developing next-generation ion implantation applications. Recent product launches, such as the Purion Power Plus series for next-generation power devices and the GSD Ovation ES implanter, are designed to enhance device performance and productivity, contributing to future revenue growth.
  • Strategic Merger with Veeco Instruments: The recently announced merger with Veeco Instruments is a strategic move aimed at enhancing Axcelis' position in the semiconductor equipment market. This merger is expected to enable the combined company to capitalize on powerful secular tailwinds, including AI and electrification, by leveraging cross-sell synergies, expanding market presence, and strengthening capabilities in key areas.

AI Analysis | Feedback

Share Repurchases

  • Axcelis Technologies authorized additional funding of $200 million for its share repurchase program in September 2023.
  • In March 2025, the Board of Directors approved an additional $100 million in share repurchase authorization, bringing the total outstanding authorization to $215 million at that time.
  • As of September 30, 2025, the company had $135 million remaining authorized for share repurchases, having repurchased 1.5 million shares year-to-date at an average price of $62.33.

Share Issuance

  • Axcelis Technologies has seen a general decrease in its shares outstanding over the last few years, from approximately 33.29 million at the end of 2021 to around 31.0 million as of September 30, 2025.
  • Less than 0.1 million shares were purchased under the 2020 Employee Stock Purchase Plan (ESPP) in both 2022 and 2023, with 0.1 million shares purchased in 2024.

Outbound Investments

  • On October 1, 2025, Axcelis Technologies and Veeco Instruments announced an agreement to merge in an all-stock transaction, with the closing expected in the second half of 2026.
  • In this merger, each Veeco share will convert into 0.3575 Axcelis shares.

Capital Expenditures

  • Capital expenditures were $8.7 million in 2021, $11 million in 2022, $21 million in 2023, and $12 million in 2024.
  • Projected capital expenditures include $11 million for 2025 and $12 million for 2026.
  • The focus of capital expenditures includes expanding manufacturing capabilities, such as the Axcelis Asia Operations Center in South Korea (opened November 2021) and a state-of-the-art logistics and flex manufacturing center in Beverly, Massachusetts.

Better Bets vs. Axcelis Technologies (ACLS)

Trade Ideas

Select ideas related to ACLS.

Unique Key

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

ACLSAMATLRCXKLACVECOONTOMedian
NameAxcelis .Applied .Lam Rese.KLA Veeco In.Onto Inn. 
Mkt Price83.20318.75229.971,352.2630.07199.04214.50
Mkt Cap2.6253.4288.6177.51.89.893.6
Rev LTM85328,36820,56112,7456811,0026,873
Op Inc LTM1388,4706,9425,351691692,760
FCF LTM1245,6986,2164,377552612,319
FCF 3Y Avg1666,9265,0453,636472051,920
CFO LTM1387,9587,1224,766732892,528
CFO 3Y Avg1828,4455,6453,963682332,098

Growth & Margins

ACLSAMATLRCXKLACVECOONTOMedian
NameAxcelis .Applied .Lam Rese.KLA Veeco In.Onto Inn. 
Rev Chg LTM-20.7%4.4%26.8%17.5%-3.9%6.4%5.4%
Rev Chg 3Y Avg1.6%3.2%5.1%7.3%2.0%1.4%2.6%
Rev Chg Q-16.7%-3.5%22.1%7.2%-10.2%-13.5%-6.9%
QoQ Delta Rev Chg LTM-4.8%-0.9%4.9%1.8%-2.7%-3.3%-1.8%
Op Mgn LTM16.1%29.9%33.8%42.0%10.1%16.8%23.3%
Op Mgn 3Y Avg20.1%29.2%30.3%38.9%10.5%17.7%24.7%
QoQ Delta Op Mgn LTM-1.7%-0.3%0.8%0.2%-1.7%-2.1%-1.0%
CFO/Rev LTM16.1%28.1%34.6%37.4%10.7%28.9%28.5%
CFO/Rev 3Y Avg17.9%30.9%33.2%35.7%10.0%24.8%27.9%
FCF/Rev LTM14.5%20.1%30.2%34.3%8.0%26.1%23.1%
FCF/Rev 3Y Avg16.4%25.4%29.7%32.7%7.0%21.7%23.5%

Valuation

ACLSAMATLRCXKLACVECOONTOMedian
NameAxcelis .Applied .Lam Rese.KLA Veeco In.Onto Inn. 
Mkt Cap2.6253.4288.6177.51.89.893.6
P/S3.18.914.013.92.79.79.3
P/EBIT16.026.640.232.233.757.832.9
P/E19.236.246.438.936.755.737.8
P/CFO18.931.840.537.224.833.732.8
Total Yield5.1%3.3%2.6%3.1%2.7%1.8%2.9%
Dividend Yield0.0%0.5%0.4%0.6%0.0%0.0%0.2%
FCF Yield 3Y Avg5.8%4.7%4.0%3.6%2.9%2.6%3.8%
D/E0.00.00.00.00.10.00.0
Net D/E-0.2-0.0-0.00.0-0.1-0.1-0.0

Returns

ACLSAMATLRCXKLACVECOONTOMedian
NameAxcelis .Applied .Lam Rese.KLA Veeco In.Onto Inn. 
1M Rtn-3.4%18.6%24.3%6.1%-1.5%20.0%12.3%
3M Rtn3.3%38.7%47.9%13.5%3.5%54.2%26.1%
6M Rtn6.7%78.8%138.7%53.7%50.8%110.1%66.2%
12M Rtn26.6%80.1%189.4%84.2%19.8%-0.1%53.3%
3Y Rtn-29.5%172.9%348.4%241.1%41.6%131.0%152.0%
1M Excs Rtn-4.2%17.7%23.4%5.2%-2.4%19.1%11.5%
3M Excs Rtn3.5%35.9%45.2%10.9%3.5%46.4%23.4%
6M Excs Rtn8.2%65.9%125.3%39.0%35.9%95.5%52.4%
12M Excs Rtn8.0%64.0%171.8%70.3%3.9%-17.3%36.0%
3Y Excs Rtn-93.6%121.1%321.5%178.9%-19.9%85.2%103.1%

Comparison Analyses

Financials

Segment Financials

Revenue by Segment
$ Mil20242023202220212020
Ion implantation systems and services1,111898646457326
Other systems and services1922171817
Total1,131920662475343


Price Behavior

Price Behavior
Market Price$84.37 
Market Cap ($ Bil)2.6 
First Trading Date07/11/2000 
Distance from 52W High-16.0% 
   50 Days200 Days
DMA Price$87.26$77.40
DMA Trendupup
Distance from DMA-3.3%9.0%
 3M1YR
Volatility49.5%53.7%
Downside Capture369.75198.81
Upside Capture356.99194.84
Correlation (SPY)67.6%59.9%
ACLS Betas & Captures as of 1/31/2026

 1M2M3M6M1Y3Y
Beta3.953.552.922.311.671.92
Up Beta4.232.741.411.481.451.73
Down Beta2.072.702.252.271.551.57
Up Capture627%501%489%353%348%1324%
Bmk +ve Days11223471142430
Stock +ve Days12223161125357
Down Capture488%371%291%216%144%113%
Bmk -ve Days9192754109321
Stock -ve Days8193064124392

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ACLS
ACLS27.7%53.7%0.65-
Sector ETF (XLK)23.8%27.0%0.7663.4%
Equity (SPY)15.6%19.2%0.6360.0%
Gold (GLD)77.2%24.5%2.306.3%
Commodities (DBC)10.0%16.5%0.4016.9%
Real Estate (VNQ)2.9%16.5%-0.0036.6%
Bitcoin (BTCUSD)-23.4%40.3%-0.5629.3%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ACLS
ACLS20.0%54.0%0.54-
Sector ETF (XLK)17.6%24.7%0.6468.5%
Equity (SPY)14.5%17.0%0.6863.7%
Gold (GLD)21.5%16.8%1.047.7%
Commodities (DBC)12.0%18.9%0.5114.9%
Real Estate (VNQ)4.8%18.8%0.1637.2%
Bitcoin (BTCUSD)20.9%57.5%0.5626.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ACLS
ACLS7.8%57.3%0.43-
Sector ETF (XLK)22.9%24.2%0.8657.6%
Equity (SPY)15.6%17.9%0.7553.5%
Gold (GLD)15.6%15.5%0.845.1%
Commodities (DBC)8.4%17.6%0.3917.0%
Real Estate (VNQ)5.6%20.8%0.2433.7%
Bitcoin (BTCUSD)69.9%66.5%1.0914.8%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date1152026
Short Interest: Shares Quantity4.6 Mil
Short Interest: % Change Since 1231202515.7%
Average Daily Volume0.6 Mil
Days-to-Cover Short Interest7.7 days
Basic Shares Quantity31.3 Mil
Short % of Basic Shares14.8%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/4/2025-2.7%5.7%7.7%
8/5/202510.1%10.0%11.0%
5/6/20255.0%19.3%18.0%
2/10/2025-12.3%-6.1%-12.1%
11/6/2024-1.0%-9.4%-15.6%
7/31/2024-10.7%-18.7%-13.4%
5/1/20244.9%9.6%10.6%
2/7/2024-7.0%-8.3%-14.9%
...
SUMMARY STATS   
# Positive121315
# Negative12119
Median Positive6.1%9.6%10.6%
Median Negative-5.1%-8.3%-12.6%
Max Positive12.8%21.7%37.3%
Max Negative-13.8%-18.7%-16.9%

SEC Filings

Expand for More
Report DateFiling DateFiling
09/30/202511/06/202510-Q
06/30/202508/05/202510-Q
03/31/202505/06/202510-Q
12/31/202402/28/202510-K
09/30/202411/07/202410-Q
06/30/202408/01/202410-Q
03/31/202405/02/202410-Q
12/31/202302/23/202410-K
09/30/202311/02/202310-Q
06/30/202308/03/202310-Q
03/31/202305/05/202310-Q
12/31/202202/24/202310-K
09/30/202211/03/202210-Q
06/30/202208/04/202210-Q
03/31/202205/05/202210-Q
12/31/202102/25/202210-K

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Titinger, JorgeDirectSell1218202586.052,000172,100643,396Form
2Blumenstock, Gerald MEVP, Research, Dev. & Eng.DirectSell1212202589.463,034271,4221,669,413Form
3Kurtzweil, John TDirectSell521202561.931,682104,1662,170,646Form